Injectable phosphorous may be administered by intravenous or deep intramuscular injection. Divide high intramuscular dosages between two injection sites. Dosage range is 1 mL per 50 to 100 lbs of body weight. Dose range in cattle is 10 to 20 mL. Two injections are sufficient if the ration deficiency is immediately corrected.
Store at temperature between 15°-30°C (59° - 86°F).
For parenteral use as a supplemental source of nutritional phosphorus while the ration is being corrected in areas where feeding rations are inadequate to supply all phosporus needs for cattle.
Sodium salt of 4-dimethylamino-2-methylphenyl phosphinic acid 200 mg. Propylene glycol 100 mg. Phenylethanol 6.0 mg. Sodium sulfite 2.0 mg. Water for injection q.s., pH adjusted with sodium carbonate.
Injectable phosphorous may be administered by intravenous or deep intramuscular injection. Divide high intramuscular dosages between two injection sites. Dosage range is 1 mL per 50 to 100 lbs of body weight. Dose range in cattle is 10 to 20 mL. Two injections are sufficient if the ration deficiency is immediately corrected.
Store at temperature between 15°-30°C (59° - 86°F).
Manufactured by Nova-Tech
Grand Island, NE 68801 for
Neogen Corporation
Lexington, KY 40511 USA
859/254-1221
L567-92011
Item No. 09070
RMS# 92-303
Made in USA
Net Contents: 100 mL
Lot No.
Exp. Date
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59051-9070 | 59051-9070-5 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| 1-PHENYLETHANOL | E6O895DQ52 | IACT |
| SODIUM SULFITE | VTK01UQK3G | IACT |
| WATER | 059QF0KO0R | IACT |
| TOLDIMFOS SODIUM | 6139240O1E | ACTIM |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.